Abstracts
Gastric and intestinal phenotypic cell markers are widely expressed in gastric carcinomas, irrespective of their histological type. In the present study, the relations between the phenotypic marker expression of the tumour, histological findings, expression of cell adhesion molecules, and the chromosomal changes in gastric differentiated-type carcinomas were examined. The phenotypic marker expression of the tumour was determined by the combination of the expression of the human gastric mucin (HGM), MUC6, MUC2 and CD10, and was evaluated in comparison with the expression of cell adhesion molecules, such as E-cadherin and β-catenin, and chromosomal changes by comparative genomic hybridization (CGH) in 34 gastric differentiated-type carcinomas. Tumours were classified into the gastric- (G-), gastric and intestinal mixed- (GI-), intestinal- (I-), or unclassified- (UC-) phenotype according to the immunopositivity of staining for HGM, MUC6, MUC2, and CD10. G-phenotype tumours were significantly associated with a higher incidence of differentiated-type tumours mixed with undifferentiated-type component, compared with GI- and I-phenotype tumours (88.9 vs 33.3%, P=0.0498 and 88.9 vs 42.9%, P=0.0397; respectively). HGM-positive tumours were significantly associated with a higher incidence of tumours with abnormal expression of E-cadherin, compared with HGM-negative tumours (66.7 vs 21.1%, P=0.0135). GI-phenotype tumours were significantly associated with a higher incidence of tumours with abnormal expression of E-cadherin, compared with I-phenotype tumours (77.8 vs 21.4%, P=0.0131). HGM-negative tumours were significantly associated with higher frequencies of the gains of 19q13.2 and 19q13.3, compared with HGM-positive tumours (57.9 vs 20.0%, P=0.0382 and 63.2 vs 13.3%, P=0.0051; respectively). MUC6-positive tumours were significantly associated with higher frequencies of the gains of 20q13.2, compared with MUC6-negative tumours (71.4 vs 30.0%, P=0.0349). MUC2-positive tumours were significantly associated with the gain of 19p13.3, compared with MUC2-negative tumours (41.2 vs 5.9%, P=0.0391). I-phenotype tumours were significantly associated with higher frequencies of gains of 5p15.2 and 13q33-34, compared with G-phenotype tumours (66.7 vs 0%, P=0.0481, each) and also associated with higher frequencies of gain of 7p21, compared with GI-phenotype tumours (66.7 vs 0%, P=0.0481). Our present results show that gastric differentiated-type carcinomas have different characteristics according to the phenotypic marker expression of the tumour in terms of histological findings, E-cadherin expression and pattern of chromosomal changes.
Similar content being viewed by others
References
Baldus SE, Zirbes TK, Engel S, Hanisch FG, Monig SP, Lorenzen J, Glossmann J, Fromm S, Thiele J, Pichlmaier H, Dienes HP (1998) Correlations of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis. Int J Cancer 79:133–138
Bara J, Chastre E, Mahiou J, Singh RL, Forgue-Lafitte ME, Hollande E, Godeau F (1998) Gastric M1 mucin, an early oncofetal marker of colon carcinogenesis, is encoded by the MUC5AC gene. Int J Cancer 75:767–773
Dean FB, Nelson JR, Giesler TL et al (2001) Rapid amplification of plasmid and phage DNA using Phi29 DNA polymerase and multiply-primed rolling circle amplification. Genome Res 11:1095–1099
De Bolos C, Garrido M, Real FX (1995) MUC6 apomucin shows a distinct normal tissue distribution that correlates with Lewis antigen expression in the human stomach. Gastroenterology 109:723–734
Egashira Y, Shimoda T, Ikegami M (1999) Mucin histochemical analysis of minute gastric differentiated adenocarcinoma. Pathol Int 49:55–61
El-Rifai W, Harper JC, Cummings OW, Hyytinen ER, Frierson HF, Knuutila S, Powell SM (1998) Consistent genetic alterations in xenografts of proximal stomach and gastro-esophageal junction adenocarcinomas. Cancer Res 58:34–37
Endoh Y, Tamura G, Motoyama T, Ajioka Y, Watanabe H (1999a) Well-differentiated adenocarcinoma mimicking complete-type intestinal metaplasia in the stomach. Hum Pathol 30:826–832
Endoh Y, Tamura G, Watanabe H, Ajioka Y, Motoyama T (1999b) The common 18-base pair deletion at codons 418–423 of the E-cadherin gene in differentiated-type adenocarcinomas and intramucosal precancerous lesions of the stomach with the features of gastric foveolar epithelium. J Pathol 189:201–206
Endoh Y, Sakata K, Tamura G, Ohmura K, Ajioka Y, Watanabe H, Motoyama T (2000a) Cellular phenotypes of differentiated-type adenocarcinomas and precancerous lesions of the stomach are dependent on the genetic pathways. J Pathol 191:257–263
Endoh Y, Tamura G, Ajioka Y, Watanabe H, Motoyama T (2000b) Frequent hypermethylation of the hMLH1 gene promoter in differentiated-type tumours of the stomach with the gastric foveolar phenotype. Am J Pathol 157:717–22
Hsu SM, Raine L, Fanger H (1981) Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577–580
Japanese Gastric Cancer Association (1998) Japanese classification of gastric carcinoma-2nd English ed. Gastric Cancer 1:10–24
Jawhari A, Jordan S, Poole S, Browne P, Pignatelli M, Farthing MJG (1997) Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival. Gastroenterology 112:46–54
Kabashima A, Yao T, Sugimachi K, Tsuneyoshi M (2002) Relationship between biologic behaviour and phenotypic expression in intramucosal gastric carcinomas. Hum Pathol 33:80–86
Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D (1992) Comparative genomic hybridization for molecular cytogenetic analysis of solid tumours. Science 258:818–821
Kim YS, Gum JR (1995) Diversity of mucin genes, structure, function and expression. Gastroenterology 109:999–1013
Knuutila S, Autio K, Aalto Y (2000) Online access to CGH data of DNA sequence copy number changes. Am J Pathol 157:689
Kokkola A, Monni O, Puolakkainen P, Larramendy ML, Victorzon M, Nordling S, Haapiainen R, Kivilaakso E, Knuutila S (1997) 17q12–21 amplicon, a novel recurrent genetic change in intestinal type of gastric carcinoma: a comparative genomic hybridization study. Genes Chromosomes Cancer 20:38–43
KoizumiY, Tanaka S, Mou R, Koganei H, Kokawa A, Kitamura R, Yamauchi H, Ookubo K, Saito T, Tominaga S, Matsumura K, Shimada H, Tsuchida N, Sekihara H (1997) Changes in DNA copy number in primary gastric carcinomas by comparative genomic hybridization. Clin Cancer Res 3:1067–1076
Koseki K, Takizawa T, Koike M, Ito M, Nihei Z, Sugihara K (2000) Distinction of differentiated type early gastric carcinoma with gastric type mucin expression. Cancer 89:724–732
Kushima R, Mukaisho K, Tsukashita S, Peng DF, Sugihara H, Vieth M, Hattori T, Stolte M (2003) Molecular biological characteristics of early stomach adenocarcinomas of the completely gastric phenotype revealed by laser capture microdissection and comparative genomic hybridization (in Japanese with English abstract). Stomach and Intestine 38:707–721
Lauren P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathol Microbiol Scand 64:122–129
Machado JC, Nogueira AM, Carneiro F, Reis CA, Sobrinho-Simoes M (2000) Gastric carcinoma exhibits distinct types of cell differentiation: an immunohistochemical study of trefoil peptides (TFF1 and TFF2) and mucins (MUC1, MUC2, MUC5AC, and MUC6). J Pathol 190:437–443
Morohara K, Nakao K, Tajima Y, Nishino N, Yamazaki K, Kaetsu T, Suzuki S, Tsunoda A, Kawamura M, Aida T, Tachikawa T, Kusano M (2005) Analysis by comparative genomic hybridization of gastric cancer with peritoneal dissemination and/or positive peritoneal cytology. Cancer Genet Cytogenet 161:57–62
Nakamura K, Sugano H, Takagi K (1968) Carcinoma of the stomach in incipient phase: its histogenesis and histological appearances. Gann 59:251–258
Nakao K, Shibusawa M, Ishihara A, Yoshizawa H, Tsunoda A, Kusano M, Kurose A, Makita T, Sasaki K (2001) Genomic changes in colorectal carcinoma tumours with liver metastases analyzed by comparative genomic hybridization and DNA ploidy. Cancer 91:721–726
Nessling M, Solinas-Toldo S, Wilgenbus KK, Borchard F, Lichter P (1998) Mapping of chromosomal imbalances in gastric adenocarcinoma revealed amplified protooncogenes MYCC, MET, WNT2, and ERBB2. Genes Chromosomes Cancer 23:307–316
Noguchi T, Wirtz HC, Michaelis S, Gabbert HE, Mueller W (2001) Chromosomal imbalances in gastric cancer. Am J Clin Pathol 115:828–834
Nollet S, Forgue-Lafitte ME, Kirkham P, Bara J (2002) Mapping of two new epitopes on the apomucin encoded by MUC5AC gene: expression in normal GI tract and colon tumours. Int J Cancer 99:336–343
Ochiai A, Akimoto S, Shimoyama Y, Nagafuchi A, Tsukita S, Hirohashi S (1994) Frequent loss of α-catenin expression in scirrhous carcinomas with scattered cell growth. Jpn J Cancer Res 85:266–273
Oda T, Kanai Y, Oyama T, Yoshioka K, Shinoyama Y, Birchmeier W, Sugimura T, Hirohashi S (1994) E-cadherin gene mutations in human gastric carcinoma cell lines. Proc Natl Acad Sci USA 91:1858–1862
Oyama T, Kanai Y, Ochiai A, Akimoto S, Oda T, Yanagihara K, Nagafuchi A, Tsukita S, Shibamoto S, Ito F (1994) A truncated β-catenin disrupts the interaction between E-cadherin and α-catenin: a cause of loss of intercellular adhesiveness in human cancer cell lines. Cancer Res 54:6282–6287
Reis CA, David L, Correa P, Carneiro F, De Bolos C, Garcia E, Mandel U, Clausen H, Sobrinho-Simoes M (1999) Intestinal metaplasia of human stomach displays distinct pattern of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res 59:1003–1007
Ronco P, Allegri L, Melcion C, Pirotsky E, Appay MD, Bariety J, Pontillon F, Verroust P (1984) A monoclonal antibody to brush border and passive nephritis. Clin Exp Immunol 55:319–332
Peng DF, Sugihara H, Mukaisho K, Tsubosa Y, Hattori T (2003) Alterations of chromosomal copy number during progression of diffuse-type gastric carcinomas: metaphase- and array-based comparative genomic hybridization analyses of multiple samples from individual tumours. J Pathol 201:439–450
Saito K, Shimada T (1986) Histogenesis and early invasion of gastric cancer. Acta Pathol Jpn 36:1307–1318
Saito A, Shimoda T, Nakanishi Y, Ochiai A, Toda G (2001) Histologic heterogeneity and mucin phenotypic expression in early gastric cancer. Pathol Int 51:165–171
Sakakura C, Mori T, Sakabe T, Ariyama Y, Shinomiya T, Date K, Hagiwara A, Yamaguchi T, Takahashi T, Nakamura Y, Abe T, Inazawa J (1999) Gains, losses, and amplifications of genomic materials in primary gastric cancers analyzed by comparative genomic hybridization. Genes Chromosomes Cancer 24:299–305
Sasaki I, Yao T, Nawata H, Tsuneyoshi M (1999) Minute gastric carcinoma of differentiated type with special reference to the significance of intestinal metaplasia, proliferative zone, and p53 protein during tumour development. Cancer 85:1719–1729
Sakamoto H, Yonezawa S, Utsunomiya T, Tanaka S, Kim YS, Sato E (1997) Mucin antigen expression in gastric carcinomas of young and old adults. Hum Pathol 28:1056–1065
Shibata N, Watari J, Fujiya M, Tanno S, Saitoh Y, Kohgo Y (2003) Cell kinetics and genetic instabilities in differentiated type early gastric cancers with different mucin phenotype. Hum Pathol 34:32–40
Stadtlander CT, Waterbor JW (1999) Molecular epidemiology, pathogenesis and prevention of gastric cancer. Carcinogenesis 20:2195–2208
Tahara E (1995) Genetic alterations in human gastrointestinal cancers. Cancer 75:1410–1417
Tahara E, Semba S, Tahara H (1996) Molecular biological observations in gastric cancer. Semin Oncol 23:307–315
Tajima Y, Shimoda T, Nakanishi Y, Yokoyama N, Tanaka T, Shimizu K, Saito T, Kawamura M, Kusano M, Kumagai K (2001) Gastric and intestinal phenotypic marker expression in gastric carcinomas and their prognostic significance: immunohistochemical analysis of 136 lesions. Oncology 61:212–220
Tajima Y, Yamazaki K, Nishino N, Morohara K, Yamazaki T, Kaetsu T, Suzuki S, Kawamura M, Kumagai K, Kusano M (2004) Gastric and intestinal phenotypic marker expression in gastric carcinomas and recurrence pattern after surgery–immunohistochemical analysis of 213 lesions. Br J Cancer 91:1342–1348
Takahashi H, Endo T, Yamashita K, Arimura Y, Yamamoto H, Sasaki S, Itoh F, Hirata K, Imamura A, Kondo M, Sato T, Imai K (2002) Mucin phenotype and microsatellite instability in early multiple gastric cancer. Int J Cancer 100:419–424
Takeichi M (1991) Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251:1451–1455
Tamura G, Sakata K, Maesawa C, Suzuki Y, Terashima M, Satoh K, Sekiyama S, Suzuki A, Eda Y, Satodate R (1995) Microsatellite alterations in adenoma and differentiated adenocarcinoma of the stomach. Cancer Res 55:1933–1936
Tatematsu M, Furihata C, Katsuyama T, Miki K, Honda H, Konishi Y, Ito N (1986) Gastric and intestinal phenotypic expressions of human signet ring cell carcinomas revealed by their biochemistry, mucin histochemistry, and ultrastructure. Cancer Res 46:4866–4872
Tatematsu M, Ichinise M, Miki M, Hasegawa R, Kato T, Ito N (1990) Gastric and intestinal phenotypic expression of human stomach cancers as revealed by pepsinogen immunohistochemistry and mucin histochemistry. Acta Pathol Jpn 40:494–504
Tatematsu M, Tsukamoto T, Inada K (2003) Stem cells and gastric cancer: role of gastric and intestinal mixed intestinal metaplasia. Cancer Sci 94:135–41
Trejdosiewicz LK, Malizia G, Oakes J, Losowsky MS, Janossy G (1985) Expression of common acute lymphoblastic leukaemia antigen (CALLA gp100) in the brush border of normal jejunum and jejunum of patients with coeliac disease. J Clin Pathol 38:1002–1006
Utsunomiya T, Yonezawa S, Sakamoto H, Kitamura H, Hokita S, Aiko T, Tanaka S, Irimura T, Kim YS, Sato E (1998) Expression of MUC1 and MUC2 mucins in gastric carcinoma: its relationship with the prognosis of the patients. Clin Cancer Res 4:2605–2614
van Dekken H, Geelen E, Dinjens WN, Wijnhoven BP, Tilanus HW, Tanke HJ, Rosenberg C (1999) Comparative genomic hybridization of cancer of the gastroesophageal junction: deletion of 14q31–32.1 discriminates between esophageal (Barrett’s) and gastric cardia adenocarcinomas. Cancer Res 59:748–752
Vidgren V, Kokkola A, Monni O, Puolakkainen P, Nordling S, Kallioniemi A, Kivilaakso E, Knuutila S (1999) Concomitant gastrin and ERBB2 gene amplifications at 17q12-q21 in intestinal type of gastric cancer. Genes Chromosomes Cancer 24:24–29
Wu CW, Chen GD, Fann CSJ, Lee AFY, Chi CW, Liu JM, Weier Ulli, Chen JY (2002) Clinical implications of chromosomal abnormalities in gastric adenocarcinomas. Genes Chromosomes Cancer 35:219–231
Acknowledgements
This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Morohara, K., Tajima, Y., Nakao, K. et al. Gastric and intestinal phenotypic cell marker expressions in gastric differentiated-type carcinomas: association with E-cadherin expression and chromosomal changes. J Cancer Res Clin Oncol 132, 363–375 (2006). https://doi.org/10.1007/s00432-005-0062-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-005-0062-8